Baader Bank »

Adaptimmune Therapeutics shares owned by Baader Bank

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Baader Bank from 13F filings

Historical chart of Baader Bank investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Baader Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Baader Bank

Quarter filed Position value Share count Share price at filing
2025-06-30 $2.2k 15k 0.15
2024-12-31 $8.7k 18k 0.48
2024-06-30 $8.2k 10k 0.79